Hemangioblastomas
Hemangioblastomas are benign tumors that primarily occur in the nervous system, characterized by a network of blood vessels and often associated with a cystic component. The most common sites for these tumors are the cerebellum, which plays a crucial role in coordinating movement, and the spinal cord, although they can occasionally appear on other nerves. While hemangioblastomas are not typically cancerous, their growth can lead to increased pressure in the brain, affecting neurological functions. They are often linked to von Hippel-Lindau (VHL) disease, a genetic condition where approximately 75% of affected individuals develop these tumors along with other growths.
The incidence of hemangioblastomas is relatively low, accounting for only about 2% of all brain and spinal cord neoplasms. Symptoms vary depending on the tumor's location; cerebellar hemangioblastomas can cause coordination issues and dizziness, while spinal tumors may lead to pain and progressive dysfunction. Diagnosis typically involves magnetic resonance imaging (MRI), and surgical removal is the preferred treatment, although risks need to be weighed against benefits. Post-surgery, patients require regular follow-ups to monitor for potential recurrence, as about 25% may develop new hemangioblastomas, particularly those with VHL disease. Advances in treatment options, including targeted therapies and radiosurgery, are continually being explored to improve patient outcomes.
On this Page
Hemangioblastomas
ALSO KNOWN AS: Lindau tumors
RELATED CONDITIONS: Von Hippel-Lindau disease
DEFINITION: Hemangioblastomas are benign tumors of the nervous system. These tumors form a knot of blood vessels and may be surrounded by a hollow cyst containing a yellowish fluid. The most common location for hemangioblastomas is the cerebellum. The cerebellum is the part of the brain located at the base of the back of the head. Its primary function is to coordinate voluntary movement. The second most common location for hemangioblastomas is on the spinal cord. Only rarely are hemangioblastomas found on other nerves. Although hemangioblastomas are not usually cancerous, their growth can increase pressure in the brain and interfere with brain and spinal cord functions.
Risk factors: Men develop hemangioblastomas at 1.5 to two times the rate of women. Most hemangioblastomas are diagnosed in people between the ages of twenty and fifty.
Etiology and the disease process: Genetic abnormalities are thought to be the underlying cause of hemangioblastomas. Approximately 75 percent of people with von Hippel-Lindau (VHL) disease develop hemangioblastomas. VHL is a hereditary disorder in which hemangioblastomas form along with other tumors of the adrenal gland, pancreas, and kidney.
Incidence: Hemangioblastomas are rare. They make up only about 2 percent of all abnormal growths (neoplasms) on the brain and spinal cord.
Symptoms: Symptoms depend on the location of the tumor. In the cerebellum, hemangioblastomas can cause a lack of coordination, problems with balance, dizziness, and headache. On the spinal cord, they can cause pain and progressive dysfunction.
Screening and diagnosis: Hemangioblastomas are not routinely screened. They are diagnosed by magnetic resonance imaging (MRI) studies. If a hemangioblastoma is suspected, imaging studies such as a computed tomography (CT) scan, angiography, and ultrasound are performed to provide additional information before surgery. Doctors may also perform blood tests to check for mutations in the VHL gene. There is no staging for hemangioblastomas.
Treatment and therapy: Hemangioblastomas are surgically removed unless the risks of the operation are greater than the expected benefits. Depending on the location of the tumor, damage to surrounding brain tissue may occur during surgery. Microsurgical techniques, as well as the use of imaging during surgery, have improved surgical success rates for hemangioblastomas. After surgery, regular follow-up visits are needed to check for recurrent tumors. Advances continue to be made in the treatment of hemanioblastomas, including the use of brachytherapy and immunotherapy in conjunction with surgery to more effectively target the tumor and non-invasive stereotactic radiosurgery, which relies more heavily on radiation.
Prognosis, prevention, and outcomes: The outcome of surgery depends largely on the location of the hemangioblastoma, but it is usually good. About 25 percent of patients develop additional hemangioblastomas. The recurrence rate is higher in younger individuals and in those with VHL disease.
Bibliography
Ahadi, Mahsa, et al. "Hemangioblastoma of the Central Nervous System: A Case Series of Patients Surgically Treated at Shohada-e-Tajrish Hospital, Tehran, Iran during 2004-2014." Iranian Journal of Child Neurology, vol. 13, no. 2, 2019, pp. 163-169, www.ncbi.nlm.nih.gov/pmc/articles/PMC6451852/. Accessed 27 June 2024.
Dabbs, David J. Diagnostic Immunohistochemistry: Theranostic and Genomic Applications. 4th ed., Philadelphia: Elsevier, 2014.
“Hemangioma.” American Brain Tumor Association, May 2018, www.abta.org/tumor‗types/hemangioma. Accessed 27 June 2024.
“Hemangioblastoma Treatment.” Pacific Neuroscience Institute, 30 June 2023, www.pacificneuroscienceinstitute.org/brain-tumor/conditions/hemangioblastoma. Accessed 27 June 2024.
Mazzapicchi, Elio, et al. "Sporadic and Von Hippel–Lindau Related Hemangioblastomas of Brain and Spinal Cord: Multimodal Imaging for Intraoperative Strategy." Cancers, vol. 14, no. 22, 2022, doi.org/10.3390/cancers14225492. Accessed 27 June 2024.
Naidich, Thomas P., Mauricio Castillo, Soonmee Cha, and James G. Smirniotopoulos. Imaging of the Brain. Philadelphia: Elsevier, 2013.
Nguyen, Thinh H., et al. "Von Hippel-Lindau with Early Onset of Hemangioblastoma and Multiple Drop-metastases like Spinal Lesions: A Case Report." Medicine, vol. 97, no. 39, 2018, doi.org/10.1097/MD.0000000000012477. Accessed 27 June 2024.
Samii, Madjid, and Venelin Gerganov. Surgery of Cerebellopontine Lesions. New York: Springer, 2013.
“Von Hippel-Lindau Disease (VHL): Symptoms & Prognosis.” Cleveland Clinic, my.clevelandclinic.org/health/diseases/6118-von-hippel-lindau-disease-vhl. Accessed 27 June 2024.
Welsh, Cynthia T. Intra-Operative Neuropathology for the Non-Neuropathologist: A Case-Based Approach. New York: Springer, 2012.
Yachnis, Anthony T., and Marie L. Rivera-Zengotita. Neuropathology. Philadelphia: Elsevier, 2014.